Search
Search Results
##search.searchResults.foundPlural##
-
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3167PDF: 1684HTML: 1071 -
Tenofovir as Rescue Therapy Following Clinical Failure to Lamivudine in Severe Acute Hepatitis B
2080PDF: 796HTML: 1628Figure 1: 194 -
THE IMPACT OF HUMAN PLATELET ANTIGEN ALLELE ON ANTIPLATELET ANTIBODIES AND CRYOGLOBULINS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA AND HEPATITIS C VIRUS-ASSOCIATED IMMUNE THROMBOCYTOPENIA Human platelet antigen and immune thrombocytopenia
959PDF: 820Suppl. Files: 440HTML: 273 -
Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission
1573PDF: 722HTML: 224 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3268PDF: 565HTML: 632 -
FAMILIAL MEDITERRANEAN FEVER: ASSESSING THE OVERALL CLINICAL IMPACT AND FORMULATING TREATMENT PLANS Familial Mediterranean Fever today
4585PDF: 1787HTML: 713 -
A NEGLECTED ZOONOSIS IN ALBANIA: WHY ECHINOCOCCOSIS IS BECOMING A SURGEON’S EXCLUSIVITY?
1528PDF: 811HTML: 3767Cover letter: 204Title page: 213Figure 1: 144 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1130PDF: 1014HTML: 177 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
3805PDF: 3117HTML: 187 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
643PDF: 494HTML: 200 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3147PDF: 975HTML: 1990 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
2764PDF: 1194HTML: 2667Figure 1: 152 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1173PDF: 735HTML: 296 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3966PDF: 1014HTML: 3558Untitled: 165Cneo. Fig.1: 100Untitled: 89Untitled: 113Untitled: 116 -
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1497PDF: 880HTML: 1935Figure: 156Tables: 173ALL revision 1: 178response to reviewer: 165 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2494PDF: 923HTML: 15072 -
DYNAMIC MONITORING OF ADAMTS 13 ACTIVITY FOR DIFFERENTIAL DIAGNOSIS ACROSS THE SPECTRUM OF SEPSIS ASSOCIATED WITH THROMBOTIC MICROANGIOPATIES Adamts 13 and Sepsis Associated with Thrombotic Thrombocytopenic Purpura
567PDF: 371HTML: 74 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1563PDF: 1138HTML: 184 -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
3779PDF: 729HTML: 1827 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3516PDF: 837HTML: 6696 -
COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon in a patient with monoclonal gammopathy of undetermined significance COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon
790PDF: 788HTML: 98 -
Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated Acute Myeloid leukemia- A case report and review of literature
1820PDF: 879HTML: 1746Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated AML- IMAGES: 144 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2345PDF: 827HTML: 2440 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1628PDF: 626HTML: 2414 -
Common variable immunodeficiency due to a novel NFKB1 variant in a child with thalassemia major CVID with thalassemia major
661PDF: 525HTML: 144 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
940PDF: 519HTML: 711







